Accession Number: | 0001209191-21-055438 |
Date: | 2021-09-09 |
Issuer: | PMV PHARMACEUTICALS, INC. (PMVP) |
Original Submission Date: |
ALLAND LEILA
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3
CRANBURY, NJ 08512
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-09 | M | 100 | a | $3.90 | 100 | direct | ||
COMMON STOCK | 2021-09-09 | S | 100 | d | $30.25 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 3.9 | 2021-09-09 | deemed execution date | M | 100 (d) | 2030-02-04 | common stock 100 | $3.90 | 353,850 | direct |
ID | footnote |
---|---|
f1 | the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 30, 2020. |
f2 | one-fourth of the shares subject to the option vested on december 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. |